This campaign has now closed

We aim to address the critical need to develop more effective approaches to combat blood cancer, as surgery, raditation and chemotherapy are often limited in effectiveness. We will investigate the ability of the measles virus to selectively kill blood cancer cells, offering new hope to patients.

100%
Categories

Beneficiaries

Situation

Leukaemia is a cancer of the white blood cells and affects over 7000 people a year. Lymphoma (a common form blood cancer) affects primarily young adults. Unfortunately, there remains no guaranteed cure for these devastating cancers, as current treatments such as surgery, radiotherapy and chemotherapy are not always effective. In studying how we can boost a patient’s immune system to selectively target and kill cancer cells, we aim to develop a more effective approach to combating blood cancers.

Solution

We aim to investigate and develop a vaccine that will mobilise the immune system to selectively target blood cancer cells. In doing so, Dr. Adele Fielding and her team at the University College London are investigating the use of a non-infectious strain of the measles virus to selectively kill leukaemia and lymphoma cells. In understanding the mechanisms behind the measles’ anti-cancer effect, we aim to offer new hope to patients who do not respond well to other treatments.

100%
Categories

Beneficiaries